ARNA Genomics Integrating Bancor Protocol to Provide Token Liquidity for Millions of People

Moscow, Russia — February 2, 2018 — ARNA Genomics, an innovative Precision Medicine and Blockchain technology company specializing in the development of blood tests for early diagnosis of cancer and monitoring the efficacy of cancer treatment using blockchain, has today announced its integration of the Bancor Protocol.

By integrating the Bancor Protocol, ARNA Token holders will gain access to continuous liquidity regardless of trade volume or exchange listings, through the Bancor Network, where any integrated token can be automatically converted to any Ethereum-based token directly from a Web3 wallet such as MetaMask. The Bancor Network currently includes a long list of projects that have already integrated the Bancor Protocol and the ARNA team is extremely excited to be among such projects as EOS, KIN, BNB, OMG and many others! ARNA will be allocating 2% of the total supply of ARNA to activate its Relay Token on the Bancor Network one week after the ARNA Token Generation Event concludes.

“We anticipate massive demand for the ARNA Token, supported by a large and engaged community that recognizes the value of our tests for early detection of cancer as well as the services offered by other biomed technologies on the ARNA platform. We have already opened a waiting list for people who want to pay in tokens for the ARNA Breast Cancer test (ARNA BC test)” said Egor Melnikov, CEO of ARNA. “Integrating Bancor will provide liquidity to anyone using our platform to support blockchain-based cancer research and detection or, as we call it, ‘mining healthcare’.”

ARNA BC is the world’s most accurate early-stage breast cancer test with a 96% accuracy score, exceeding all known tests for breast cancer. The proprietary technological platform of liquid biopsy is synergically tied with ARNA Panacea, a biotech decentralized solution powered by blockchain as the platform for verification of BioMed technologies.

More than 37,000 members of the crypto community communicate with ARNA Genomics every day online in social networks, highlighting the widespread interest in the company’s products.

About ARNA Genomics

ARNA Genomics is an innovative biotechnological company, launched on the basis of the scientific research of a team like-minded people who engage actively in the development of early detection methods of oncological diseases, aiming to launch diagnostic tests for early cancer detection on the global market. ARNA Genomics has set out on a mission to increase life expectancy and significantly reduce human mortality by means of the global market launch of most recent and unique in their efficiency methods of screening (screening study with the purpose of detection and prevention of diseases development in population), diagnostics and monitoring of treatment process of oncological diseases. For more information, please visit www.token.arnagenomics.com

About Bancor

Bancor Protocol™ is a standard for the creation of Smart Tokens™, cryptocurrencies with built-in convertibility directly through their smart contracts. Bancor utilizes an innovative token “Connector” method to enable formulaic price calculation and continuous liquidity for all compliant tokens, without needing to match two parties in an exchange. Smart Tokens interconnect to form token liquidity networks, allowing user-generated cryptocurrencies to thrive. For more information, visit the website and read the Bancor Protocol™ white paper.